tiprankstipranks
Trending News
More News >
China Medical System Holdings Ltd. (CHSYF)
OTHER OTC:CHSYF
US Market

China Medical System Holdings (CHSYF) Ratios

Compare
12 Followers

China Medical System Holdings Ratios

CHSYF's free cash flow for Q4 2024 was ¥0.00. For the 2024 fiscal year, CHSYF's free cash flow was decreased by ¥ and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.30 4.29 3.07 3.55 5.46
Quick Ratio
2.03 3.98 2.90 3.32 5.04
Cash Ratio
0.88 2.10 1.52 1.63 2.93
Solvency Ratio
1.31 1.20 1.16 1.09 1.71
Operating Cash Flow Ratio
1.65 1.22 1.24 1.20 2.95
Short-Term Operating Cash Flow Coverage
3.68 1.97 1.99 2.26 269.20K
Net Current Asset Value
¥ 1.90B¥ 6.62B¥ 5.81B¥ 4.42B¥ 3.38B
Leverage Ratios
Debt-to-Assets Ratio
0.06 0.07 0.10 0.11 0.05
Debt-to-Equity Ratio
0.08 0.08 0.12 0.13 0.05
Debt-to-Capital Ratio
0.07 0.08 0.11 0.12 0.05
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.04 0.05
Financial Leverage Ratio
1.18 1.14 1.22 1.24 1.15
Debt Service Coverage Ratio
2.95 1.85 1.84 2.89 101.40
Interest Coverage Ratio
46.87 58.65 81.91 136.75 119.25
Debt to Market Cap
0.03 0.04 0.07 0.06 0.03
Interest Debt Per Share
0.31 0.55 0.76 0.71 0.25
Net Debt to EBITDA
-0.24 -1.03 -0.67 -0.45 -0.68
Profitability Margins
Gross Profit Margin
74.85%76.24%76.89%74.93%73.92%
EBIT Margin
41.89%33.85%41.66%41.80%40.94%
EBITDA Margin
45.24%36.47%42.07%44.44%43.94%
Operating Profit Margin
43.41%33.85%43.94%46.37%47.25%
Pretax Profit Margin
40.96%35.86%41.12%41.46%40.54%
Net Profit Margin
32.28%29.96%35.62%36.19%36.43%
Continuous Operations Profit Margin
32.20%29.76%35.80%36.29%36.79%
Net Income Per EBT
78.82%83.55%86.61%87.29%89.86%
EBT Per EBIT
94.36%105.93%93.59%89.41%85.81%
Return on Assets (ROA)
17.55%13.54%18.36%19.09%19.92%
Return on Equity (ROE)
20.70%15.47%22.34%23.66%22.93%
Return on Capital Employed (ROCE)
27.40%17.30%27.03%28.16%27.84%
Return on Invested Capital (ROIC)
20.07%13.27%20.99%22.79%25.25%
Return on Tangible Assets
26.76%17.19%25.59%27.16%29.36%
Earnings Yield
7.89%7.92%12.25%11.53%14.05%
Efficiency Ratios
Receivables Turnover
3.87 4.62 4.49 3.84 4.08
Payables Turnover
34.68 13.44 11.88 14.33 13.44
Inventory Turnover
3.75 2.99 4.43 4.42 4.75
Fixed Asset Turnover
7.04 16.91 18.47 15.30 13.06
Asset Turnover
0.54 0.45 0.52 0.53 0.55
Working Capital Turnover Ratio
2.64 1.26 1.63 1.78 2.29
Cash Conversion Cycle
181.03 174.14 133.01 152.01 139.04
Days of Sales Outstanding
94.27 79.07 81.36 94.97 89.40
Days of Inventory Outstanding
97.28 122.23 82.37 82.52 76.80
Days of Payables Outstanding
10.52 27.16 30.73 25.48 27.16
Operating Cycle
191.55 201.30 163.74 177.49 166.20
Cash Flow Ratios
Operating Cash Flow Per Share
1.03 1.02 1.45 1.01 1.09
Free Cash Flow Per Share
0.89 0.89 1.23 0.94 0.95
CapEx Per Share
0.14 0.13 0.21 0.07 0.14
Free Cash Flow to Operating Cash Flow
0.87 0.87 0.85 0.93 0.87
Dividend Paid and CapEx Coverage Ratio
2.20 1.49 1.97 1.86 2.29
Capital Expenditure Coverage Ratio
7.50 7.87 6.77 13.49 7.88
Operating Cash Flow Coverage Ratio
3.58 1.92 1.96 1.46 4.49
Operating Cash Flow to Sales Ratio
0.42 0.31 0.39 0.30 0.39
Free Cash Flow Yield
8.91%7.21%11.38%8.82%13.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
12.68 12.62 8.16 8.67 7.12
Price-to-Sales (P/S) Ratio
4.09 3.78 2.91 3.14 2.59
Price-to-Book (P/B) Ratio
2.62 1.95 1.82 2.05 1.63
Price-to-Free Cash Flow (P/FCF) Ratio
11.23 13.87 8.79 11.33 7.66
Price-to-Operating Cash Flow Ratio
9.73 12.11 7.49 10.49 6.69
Price-to-Earnings Growth (PEG) Ratio
1.88 -0.48 0.91 0.44 0.24
Price-to-Fair Value
2.62 1.95 1.82 2.05 1.63
Enterprise Value Multiple
8.81 9.34 6.25 6.61 5.22
Enterprise Value
24.21B 27.30B 24.04B 24.49B 15.94B
EV to EBITDA
8.81 9.34 6.25 6.61 5.22
EV to Sales
3.99 3.41 2.63 2.94 2.29
EV to Free Cash Flow
10.93 12.49 7.94 10.61 6.78
EV to Operating Cash Flow
9.47 10.91 6.77 9.82 5.92
Tangible Book Value Per Share
2.29 4.81 3.96 3.30 2.84
Shareholders’ Equity Per Share
3.82 6.33 5.95 5.17 4.46
Tax and Other Ratios
Effective Tax Rate
0.21 0.17 0.13 0.12 0.09
Revenue Per Share
2.45 3.27 3.73 3.38 2.81
Net Income Per Share
0.79 0.98 1.33 1.22 1.02
Tax Burden
0.79 0.84 0.87 0.87 0.90
Interest Burden
0.98 1.06 0.99 0.99 0.99
Research & Development to Revenue
<0.01 0.02 0.01 0.01 <0.01
SG&A to Revenue
0.04 0.08 0.07 0.05 0.04
Stock-Based Compensation to Revenue
0.00 >-0.01 <0.01 <0.01 0.00
Income Quality
1.03 0.87 0.94 0.72 0.96
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis